Literature DB >> 12478347

Megalin and cubilin, role in proximal tubule function and during development.

Erik I Christensen1, Pierre J Verroust.   

Abstract

Epithelia lining the proximal convoluted epithelium and the visceral yolk sac in rodents are characterized by their ability to internalize and degrade many proteins facing their apical pole. It has become apparent over the last decade that this property is mediated through a very high endocytic activity and the expression of at least two distinct multiligand receptors, cubilin and megalin, characterized by the accumulation of ligand-binding units, LDL receptor class A repeats and CUB domains, respectively. We review here evidence that both receptors are involved in proximal tubule function and embryonic development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478347     DOI: 10.1007/s00467-002-0956-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

Review 1.  DENTAL ENAMEL FORMATION AND IMPLICATIONS FOR ORAL HEALTH AND DISEASE.

Authors:  Rodrigo S Lacruz; Stefan Habelitz; J Timothy Wright; Michael L Paine
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

2.  Maternofetal transport of vitamin B12: role of TCblR/CD320 and megalin.

Authors:  Kaveri Arora; Jeffrey M Sequeira; Edward V Quadros
Journal:  FASEB J       Date:  2017-03-28       Impact factor: 5.191

3.  Analysis of the expression pattern of the carrier protein transthyretin and its receptor megalin in the human scalp skin and hair follicles: hair cycle-associated changes.

Authors:  Mohamed A Adly
Journal:  Histochem Cell Biol       Date:  2010-11-23       Impact factor: 4.304

4.  Molecular classification of renal tumors by gene expression profiling.

Authors:  Audrey N Schuetz; Qiqin Yin-Goen; Mahul B Amin; Carlos S Moreno; Cynthia Cohen; Christopher D Hornsby; Wen Li Yang; John A Petros; Muta M Issa; John G Pattaras; Kenneth Ogan; Fray F Marshall; Andrew N Young
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

5.  FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus.

Authors:  Jonghan Kim; Sudhasri Mohanty; Latha P Ganesan; Keding Hua; David Jarjoura; William L Hayton; John M Robinson; Clark L Anderson
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Time course of pathogenic and adaptation mechanisms in cystinotic mouse kidneys.

Authors:  Héloïse P Gaide Chevronnay; Virginie Janssens; Patrick Van Der Smissen; Francisca N'Kuli; Nathalie Nevo; Yves Guiot; Elena Levtchenko; Etienne Marbaix; Christophe E Pierreux; Stéphanie Cherqui; Corinne Antignac; Pierre J Courtoy
Journal:  J Am Soc Nephrol       Date:  2014-02-13       Impact factor: 10.121

7.  IgG is transported across the mouse yolk sac independently of FcgammaRIIb.

Authors:  Sudhasri Mohanty; Jonghan Kim; Latha P Ganesan; Gary S Phillips; Keding Hua; David Jarjoura; William L Hayton; John M Robinson; Clark L Anderson
Journal:  J Reprod Immunol       Date:  2009-12-16       Impact factor: 4.054

8.  Adaptor protein complex 2-mediated, clathrin-dependent endocytosis, and related gene activities, are a prominent feature during maturation stage amelogenesis.

Authors:  Rodrigo S Lacruz; Steven J Brookes; Xin Wen; Jaime M Jimenez; Susanna Vikman; Ping Hu; Shane N White; S Petter Lyngstadaas; Curtis T Okamoto; Charles E Smith; Michael L Paine
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

Review 9.  Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Authors:  Edgar J Rolleman; Marleen Melis; Roelf Valkema; Otto C Boerman; Eric P Krenning; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-14       Impact factor: 9.236

10.  Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.

Authors:  Erik Vegt; Annemarie Eek; Wim J G Oyen; Marion de Jong; Martin Gotthardt; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-01       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.